Format

Send to

Choose Destination
PLoS One. 2018 Feb 16;13(2):e0192910. doi: 10.1371/journal.pone.0192910. eCollection 2018.

The impact of "Option B" on HIV transmission from mother to child in Rwanda: An interrupted time series analysis.

Author information

1
Rwanda Biomedical Center, Kigali, Rwanda.
2
Partners In Health/Inshuti Mu Buzima, Rwinkwavu, Rwanda.
3
Brigham and Women's Hospital, Boston, MA, United States of America.
4
The University of British Columbia, Vancouver, British Columbia, Canada.
5
University of Rwanda, Kigali, Rwanda.
6
Harvard Medical School, Boston, MA, United States of America.

Abstract

BACKGROUND:

Nearly a quarter of a million children have acquired HIV, prompting the implementation of new protocols-Option B and B+-for treating HIV+ pregnant women. While efficacy has been demonstrated in randomized trials, there is limited real-world evidence on the impact of these changes. Using longitudinal, routinely collected data we assessed the impact of the adoption of WHO Option B in Rwanda on mother to infant transmission.

METHODS:

We used interrupted time series analysis to evaluate the impact of Option B on mother-to-child HIV transmission in Rwanda. Our primary outcome was the proportion of HIV tests in infants with positive results at six weeks of age. We included data for 20 months before and 22 months after the 2010 policy change.

RESULTS:

Of the 15,830 HIV tests conducted during our study period, 392 tested positive. We found a significant decrease in both the level (-2.08 positive tests per 100 tests conducted, 95% CI: -2.71 to -1.45, p < 0.001) and trend (-0.11 positive tests per 100 tests conducted per month, 95% CI: -0.16 to -0.07, p < 0.001) of test positivity. This represents an estimated 297 fewer children born without HIV in the post-policy period or a 46% reduction in HIV transmission from mother to child.

CONCLUSIONS:

The adoption of Option B in Rwanda contributed to an immediate decrease in the rate of HIV transmission from mother to child. This suggests other countries may benefit from adopting these WHO guidelines.

PMID:
29451925
PMCID:
PMC5815596
DOI:
10.1371/journal.pone.0192910
[Indexed for MEDLINE]
Free PMC Article

Supplemental Content

Full text links

Icon for Public Library of Science Icon for PubMed Central
Loading ...
Support Center